Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Randomized, Single-Dose, 2-way Crossover Bioequivalence Study of Paroxetine Hydrochloride 20 mg Tablets and Paxil® Under Fasting Conditions and Under Fed Conditions in Chinese Healthy Volunteers

NCT03504475 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.

NCT NCT03504475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03504475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Randomized, Single-Dose, 2-way Crossover Bioequivalence Study of Paroxetine Hydrochloride 20 mg Tablets and Paxil® Under Fasting Conditions and Under Fed Conditions in Chinese Healthy Volunteers
Lead sponsor
Beijing Tongren Hospital
Phase
Phase 1
Overall status
Completed
Start date
March 29, 2018
Completion date
June 16, 2018
Enrollment
53 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

generalized anxiety disorder, major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder